The role of fresh frozen plasma in reducing the volume of anti-snake venom in snakebite envenomation

Subraya Krishna Holla, Harish A. Rao, Damodara Shenoy, Archith Boloor, Manaswitha Boyanagari

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Snakebite associated with a venom-induced consumption coagulopathy (VICC) is a major public health problem. Our study aims to evaluate if fresh frozen plasma (FFP), administered after anti-snake venom (ASV), restores coagulability rapidly. At admission, all snakebite victims with a whole blood clotting time (WBCT) >20 min received ten vials of ASV according to World Health Organization criteria. After 6 h, at the discretion of the physician, patients with WBCT >20 min were divided into two groups. The test group received both ASV and FFP and the control group received ASV only. The mean number of ASVs used in tests and controls were 17 and 31, respectively. The clotting time normalised at 24 h and 42 h in the test group and control group, respectively. FFP appears to aid restoration of clotting factors more rapidly and thus haemorrhage and the number of anti-snake venom vials used are both reduced.

Original languageEnglish
JournalTropical Doctor
DOIs
Publication statusAccepted/In press - 01-01-2018

Fingerprint

Antivenins
Snake Bites
Snake Venoms
Blood Coagulation
Control Groups
Blood Coagulation Factors
Disseminated Intravascular Coagulation
Venoms
Public Health
Hemorrhage
Physicians

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

@article{4a3a1187cc8b4ba78613298ae10020ae,
title = "The role of fresh frozen plasma in reducing the volume of anti-snake venom in snakebite envenomation",
abstract = "Snakebite associated with a venom-induced consumption coagulopathy (VICC) is a major public health problem. Our study aims to evaluate if fresh frozen plasma (FFP), administered after anti-snake venom (ASV), restores coagulability rapidly. At admission, all snakebite victims with a whole blood clotting time (WBCT) >20 min received ten vials of ASV according to World Health Organization criteria. After 6 h, at the discretion of the physician, patients with WBCT >20 min were divided into two groups. The test group received both ASV and FFP and the control group received ASV only. The mean number of ASVs used in tests and controls were 17 and 31, respectively. The clotting time normalised at 24 h and 42 h in the test group and control group, respectively. FFP appears to aid restoration of clotting factors more rapidly and thus haemorrhage and the number of anti-snake venom vials used are both reduced.",
author = "Holla, {Subraya Krishna} and Rao, {Harish A.} and Damodara Shenoy and Archith Boloor and Manaswitha Boyanagari",
year = "2018",
month = "1",
day = "1",
doi = "10.1177/0049475518756083",
language = "English",
journal = "Tropical Doctor",
issn = "0049-4755",
publisher = "SAGE Publications Ltd",

}

The role of fresh frozen plasma in reducing the volume of anti-snake venom in snakebite envenomation. / Holla, Subraya Krishna; Rao, Harish A.; Shenoy, Damodara; Boloor, Archith; Boyanagari, Manaswitha.

In: Tropical Doctor, 01.01.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The role of fresh frozen plasma in reducing the volume of anti-snake venom in snakebite envenomation

AU - Holla, Subraya Krishna

AU - Rao, Harish A.

AU - Shenoy, Damodara

AU - Boloor, Archith

AU - Boyanagari, Manaswitha

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Snakebite associated with a venom-induced consumption coagulopathy (VICC) is a major public health problem. Our study aims to evaluate if fresh frozen plasma (FFP), administered after anti-snake venom (ASV), restores coagulability rapidly. At admission, all snakebite victims with a whole blood clotting time (WBCT) >20 min received ten vials of ASV according to World Health Organization criteria. After 6 h, at the discretion of the physician, patients with WBCT >20 min were divided into two groups. The test group received both ASV and FFP and the control group received ASV only. The mean number of ASVs used in tests and controls were 17 and 31, respectively. The clotting time normalised at 24 h and 42 h in the test group and control group, respectively. FFP appears to aid restoration of clotting factors more rapidly and thus haemorrhage and the number of anti-snake venom vials used are both reduced.

AB - Snakebite associated with a venom-induced consumption coagulopathy (VICC) is a major public health problem. Our study aims to evaluate if fresh frozen plasma (FFP), administered after anti-snake venom (ASV), restores coagulability rapidly. At admission, all snakebite victims with a whole blood clotting time (WBCT) >20 min received ten vials of ASV according to World Health Organization criteria. After 6 h, at the discretion of the physician, patients with WBCT >20 min were divided into two groups. The test group received both ASV and FFP and the control group received ASV only. The mean number of ASVs used in tests and controls were 17 and 31, respectively. The clotting time normalised at 24 h and 42 h in the test group and control group, respectively. FFP appears to aid restoration of clotting factors more rapidly and thus haemorrhage and the number of anti-snake venom vials used are both reduced.

UR - http://www.scopus.com/inward/record.url?scp=85042372596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042372596&partnerID=8YFLogxK

U2 - 10.1177/0049475518756083

DO - 10.1177/0049475518756083

M3 - Article

AN - SCOPUS:85042372596

JO - Tropical Doctor

JF - Tropical Doctor

SN - 0049-4755

ER -